Effect of a Single Colecalciferol Dose on Insulin Resistance
NCT ID: NCT01075022
Last Updated: 2010-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
136 participants
INTERVENTIONAL
2009-05-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Vitamin D Repletion on Insulin Resistance
NCT00606957
Role of Vitamin D in the Prevention and Treatment of Diseases Associated With Insulin Resistance
NCT01779908
Effect of Vitamin D Deficiency and Vitamin D Supplementation on Glucose Metabolism
NCT00749918
Vitamin D, C-reactive Protein and Insulin Resistance
NCT01019642
Supplementation of Vitamin D in Patients With Type 2 Diabetes and Hypertension
NCT02204527
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D
Colecalciferol (Vitamin D3) 300.000 UI
Colecalciferol (Vitamin D3) 300.000 UI Capsule, Single Dose
Placebo
Placebo
Placebo Capsule, Single Dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colecalciferol (Vitamin D3) 300.000 UI
Colecalciferol (Vitamin D3) 300.000 UI Capsule, Single Dose
Placebo
Placebo Capsule, Single Dose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
Exclusion Criteria
* Use of metformin
* Vitamin D Use
* Hypercalcemia
* Chronic Hepatitis
* HIV
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Clinicas de Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital de Clínicas de Porto Alegre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tania Furlanetto, PhD
Role: STUDY_DIRECTOR
Federal University of Rio Grande do Sul
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
33598290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.